Incidence and Impact of Persistent Viremia on SVR Rates in Patients Receiving Direct-Acting Antiviral Therapy.

Carver AB, Zuckerman AD, DeClercq J, Choi L, Chastain CA

Open source

DOI
10.1093/ofid/ofaa569
Published
2020 Dec
Container
Open forum infectious diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ofid/ofaa569,
  title = {Incidence and Impact of Persistent Viremia on SVR Rates in Patients Receiving Direct-Acting Antiviral Therapy.},
  author = {Carver AB and Zuckerman AD and DeClercq J and Choi L and Chastain CA},
  year = {2020},
  journal = {Open forum infectious diseases},
  doi = {10.1093/ofid/ofaa569},
  url = {https://doi.org/10.1093/ofid/ofaa569}
}

RIS

TY  - JOUR
TI  - Incidence and Impact of Persistent Viremia on SVR Rates in Patients Receiving Direct-Acting Antiviral Therapy.
AU  - Carver AB
AU  - Zuckerman AD
AU  - DeClercq J
AU  - Choi L
AU  - Chastain CA
PY  - 2020
JO  - Open forum infectious diseases
DO  - 10.1093/ofid/ofaa569
UR  - https://doi.org/10.1093/ofid/ofaa569
ER  - 

APA

AB, C., AD, Z., J, D., L, C., & CA, C. (2020). Incidence and Impact of Persistent Viremia on SVR Rates in Patients Receiving Direct-Acting Antiviral Therapy.. Open forum infectious diseases. https://doi.org/10.1093/ofid/ofaa569

Source records